(Bloomberg) -- Roche Holding AG said it will pay $7.1 billion to acquire Telavant Holdings, Inc. in a bid to shore up its pipeline of experimental...
-- Roche Holding AG said it will pay $7.1 billion to acquire Telavant Holdings, Inc. in a bid to shore up its pipeline of experimental medicines.The Swiss pharmaceutical company will gain rights in the US and Japan to develop and market RVT-3101, a promising new therapy for treating inflammatory bowel disease that’s currently undergoing clinical trials. Roche will also provide a near-term milestone payment of $150 million.
I want to have more energy and tone my body. A nutritionist said to eat more carbs, fats, and food overall. People believed to be vampires in real life may have had a disease. Here's how people throughout history dealt with the beings famous in folklore.COLUMBUS, Ohio — Video moving at 3:01a ET Monday so can be linked when WDC desk opens __ With Election Day closing in, anti-abortion groups seeking to build opposition to a reproductive rights measure in Ohio are messaging heavily around a term for an abortion procedure that was once used later in pregnancy — but hasn't been legal in the U.S.
France Dernières Nouvelles, France Actualités
Similar News:Vous pouvez également lire des articles d'actualité similaires à celui-ci que nous avons collectés auprès d'autres sources d'information.
Roche Agrees to $7.1 Billion Deal for Telavant to Boost PipelineRoche Holding AG said it will pay $7.1 billion to acquire Telavant Holdings, Inc. in a bid to shore up its pipeline of experimental medicines.
Lire la suite »
Roche buys Telavant Holdings for $7.1 billionExplore stories from Atlantic Canada.
Lire la suite »
Roche buys Telavant Holdings for $7.1 billionRoche on Monday said it will buy Telavant, a developer of a new treatment for inflamatory bowel diseases, for an initial $7.1 billion from American biopharma...
Lire la suite »
Stonepeak Agrees to Buy Textainer in Deal Valued at $7.4 BillionStonepeak Partners has agreed to buy Textainer Group Holdings Ltd. in a deal that gives the container leasing firm an enterprise value of about $7.4 billion.
Lire la suite »
Roche Taps AI to Find Lung Cancer Patients After Trial SuccessRoche Holding AG’s lung cancer drug scored a big win against a standard therapy in a study this week. Now, the Swiss drugmaker is turning to artificial intelligence to find patients who can benefit.
Lire la suite »
Australia Gender Bias Costs Economy $80 Billion, Taskforce SaysAustralia needs urgent legislative changes to end economic inequality between men and women, a government taskforce found, highlighting the problem costs the economy A$128 billion ($80 billion) a year.
Lire la suite »